Eden Enters Agreement for B2Y Nematicide

Eden Research Plc signed an exclusive option agreement with Taminco BVBA’ s crop protection division to conduct market and regulatory trials with B2Y, Eden’s nematicide product. The agreement comes following a series of successful field trials conducted during the second half of 2014. Taminco BVBA is a subsidiary of Eastman Chemical Company.

The nematicide B2Y uses Eden’s naturally-derived active ingredients and GO-E Inside, Eden’s natural micro-encapsulation technology.

Advertisement

“Since August 2014, Taminco has been evaluating Eden’s nematicide product, B2Y, and has seen very good results.” said Sean Smith, Chief Executive Officer of Eden. “As such, Taminco has decided to further evaluate the product and expand the trial work to a much larger scale with a view to registering and ultimately selling the product on a global basis.”

Read more about the agreement here.

Top Articles
ADAMA Reports Fourth Quarter and Full Year 2023 Results

Hide picture